Building Metabolically Stable and Potent Anti-HIV Thioether-Lipid Analogues of Tenofovir Exalidex: A thorough Pharmacological Analysis
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Michael P D'Erasmo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Emory University College of Arts & Sciences, Atlanta, Georgia 30322, United States. Hauptthemen laut MEDLINE: Adenine, Anti-HIV Agents, Organophosphonates, Prodrugs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Center for AIDS Research, Emory University, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Inherently limited by poor bioavailability, antiviral agent tenofovir (TFV) is administered to people living with HIV in prodrug form. However, current prodrugs are prematurely metabolized, compromising access to HIV-infected cells and inducing toxicity. Inspired by lipid conjugate TFV exalidex (TXL), we recently disclosed TXL analogs with potent activity and robust hepatic stability in vitro, as well as attractive oral PK profiles in vivo. In parallel, we discovered the equipotent and equally stable hexadecylthiopropyl (HTP) derivative of TXL (2a). Reported herein are the synthetic and bioanalytic efforts that led to potent, safe, and hepatically stable HTP derivatives. While HTP analog 16h showed the most attractive PK profile in mice (55% F) discrepancies in translating in vitro cell-based results to in vivo PK data, for certain prodrugs, indicated that further in vitro/in vivo optimization is required for continued advancement of this program.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Emory University College of Arts & Sciences, Atlanta, Georgia 30322, United States.
- HIV Pathogenesis Research Unit, Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg 2000, Gauteng, South Africa.
- Department of Laboratory Medicine & Pathology, University of Washington School of Medicine, Seattle, Washington 98195, United States.
- Department of Pharmacology & Chemical Biology, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
ORCID-Profile: Nicole Pribut, Sabrina E Iskandar, Dennis C Liotta, Eric J Miller
Förderung
- NIAID NIH HHS
- Center for AIDS Research, Emory University
- National Institute of Allergy and Infectious Diseases
- National Health Laboratory Service
Zitieren
APA
D'Erasmo, M. P., Sharma, S. K., Pribut, N., Basson, A., Dasari, M., Bartsch, P., Iskandar, S. E., Giesler, K. E., Burton, S., Derdeyn, C. A., Liotta, D. C., & Miller, E. J. (2024). Building Metabolically Stable and Potent Anti-HIV Thioether-Lipid Analogues of Tenofovir Exalidex: A thorough Pharmacological Analysis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01510
Vancouver
D'Erasmo MP, Sharma SK, Pribut N, Basson A, Dasari M, Bartsch P, et al. Building Metabolically Stable and Potent Anti-HIV Thioether-Lipid Analogues of Tenofovir Exalidex: A thorough Pharmacological Analysis. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01510
BibTeX
@article{DErasmo2024,
author = {D'Erasmo, Michael P and Sharma, Savita K and Pribut, Nicole and Basson, Adriaan and Dasari, Madhuri and Bartsch, Perry and Iskandar, Sabrina E and Giesler, Kyle E and Burton, Samantha and Derdeyn, Cindy A and Liotta, Dennis C and Miller, Eric J},
title = {Building Metabolically Stable and Potent Anti-HIV Thioether-Lipid Analogues of Tenofovir Exalidex: A thorough Pharmacological Analysis},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01510}
}
EUVIMED